Recurrent malignant salivary gland neoplasms

  title={Recurrent malignant salivary gland neoplasms},
  author={M. A. Rodriguez‐Bigas and Kumao Sako and M. S. Razack and Donald P. Shedd and V. Y. Bakamjian and Nieva B. Castillo and Uma Rao},
  journal={Journal of Surgical Oncology},
  • M. A. Rodriguez‐BigasK. Sako U. Rao
  • Published 1 October 1989
  • Medicine
  • Journal of Surgical Oncology
Recurrent salivary gland malignancies present difficult therapeutic decisions and poor prognosis in many instances, and treatment becomes of a palliative nature only. As many of the salivary gland malignancies we see are of the recurrent type, the following study was done to determine the efficacy of a vigorous attempt at retreatment. During the period January 1, 1960, through December 31, 1984, 352 patients with major and minor salivary gland tumors were evaluated at our institution. There… 
3 Citations

Adenoid cystic carcinoma of the submandibular gland: Report of 6 cases

Adenoid cystic carcinoma is characterized by slow growth, frequent recurrence, and systemic spread even after long-term survival without disease, therefore adjuvant chemotherapy should be taken into consideration.

The role of fine‐needle aspiration cytology in the management of parotid tumors: A critical clinical appraisal

The exact role of FNA in the diagnostic workup of patients is defined at defining the exact role in parotid tumors.

Accuracy, predictability and prognostic implications of fine‐needle aspiration biopsy for parotid gland tumours: A retrospective case series

  • Tomer BoldesO. Hilly A. Mizrachi
  • Medicine
    Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery
  • 2021
Clinicians should take into account that FNA is inaccurate for identifying specific subtypes of malignant lesions, which may eventually delay treatment and influence outcome, and highlight the limitations of FNA as a decision-making tool in preoperative evaluation of parotid masses.



Recurrences from malignant parotid salivary gland tumors

The authors conclude that after a surgical procedure for malignant salivary gland tumors, a trial of wide field postoperative radiation therapy to high dose should be considered as part of the initial treatment.

Tumors of minor salivary origin

All cases of minor salivary neoplasm seen at Memorial Hospital during a 25‐year period are reviewed, and adenoidcystic carcinoma was the lesion most frequently encountered.

Experience with 1,360 primary parotid tumors.

Tumors of the submaxillary gland.

Salivary gland malignant neoplasms: treatment and prognosis.

The superiority of combined therapy (surgery and postoperative irradiation) in parotid cancer.

Postoperative radiation therapy proved to increase local control over surgery alone whenever there was locally advanced disease, the tumor belonged to a so-called poorly differentiated variety, or the treatment was given for a recurrent lesion.

Major salivary gland tumors: Treatment results and prognostic factors

A retrospective review of 133 patients with major salivary gland carcinomas treated between 1955 and 1981 is presented, finding that adenoid cystic carcinoma was poorly controlled, regardless of the form of treatment.

Incidence, diagnosis, and classification of salivary gland tumors. Part 1.

The authors discuss two major theories of histogenesis, itemize the various benign and malignant varieties of tumor, discuss the presentation and prognosis for each type, and present a list of factors that influence survival.

Parotid cancer: a rational basis for treatment.

A review is presented of factors influencing survival, including histopathology, lymph node metastasis, facial nerve palsy, skin involvement, size (stage), recurrence, pain, deep lobe and distant metastasis.

Management of cancer of the parotid gland.